Resisted Sprint and Plyometric Training on Lower Limb Functional Performance in Young Adult Male Football Players.

April 6, 2021 updated by: Shahnaz Hasan, PhD, Majmaah University

Effect of Resisted Sprint and Plyometric Training on Lower Limb Functional Performance in Young Adult Male Football Players. A Randomized Control Trial

This study aims to evaluate the short-term effects of resisted sprint training on sprint performance together with lower limb physiological and functional performance in young professional football players.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Ninety collegiate football players were recruited, with a mean age of 20.48 at the university campus. All of which were randomly divided into two experimental groups RST(n=30), PLT (n=30) participated in training for six weeks on alternate days (i.e., three sessions per week) and one control group (n=30) did not train. The control group was instructed to maintain regular activities and avoid any strenuous physical activity during the study. No significant between-group baseline or pre-to-post-training differences in anthropometrics were observed.

Under the Declaration of Helsinki, participants were informed about the study's possible risks and benefits, and all participants have signed informed consent before participation in the study. Ethical sub-committee of College of applied medical science, Majmaah, Saudi Arabia approved this study (Ethics Number: MUREC-Dec.15/COM-2020 / 13-2).

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Saudi Arabia
      • Riyadh, Saudi Arabia, 110045
        • Football Playground

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Young players aged between 18 and 25 years required frequent sprinting

Exclusion Criteria:

  • Current injury to lower limb.
  • Surgery affecting lower limb function.
  • Any cardio-respiratory diseases.
  • Impairments of spine or lower extremities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental-1
Resisted Sprint Training
Other: Resisted Sprint Traininig
The Participants in this group had received plyometrics exercises; double leg jumping, drop jumping, hopping, bounding and hurdling.
Other Names:
  • Plyometric Training
Experimental: Experimental-2
Plyometric Training
Other: Resisted Sprint Traininig
The Participants in this group had received plyometrics exercises; double leg jumping, drop jumping, hopping, bounding and hurdling.
Other Names:
  • Plyometric Training
No Intervention: Control
No Training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Extensors Strength Test.
Time Frame: After 6 weeks of intervention.
Pretest and post intervention strength measure.
After 6 weeks of intervention.
Sprint Test.
Time Frame: After 6 weeks of intervention.
Pretest and post intervention sprint measure.
After 6 weeks of intervention.
Single-Leg Triple Hop Test.
Time Frame: After 6 weeks of intervention.
Pretest and post intervention single-leg triple hop measure.
After 6 weeks of intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Majmaah University

Investigators

  • Principal Investigator: Shahnaz Hasan, PhD, Majmaah University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 16, 2020

Primary Completion (Actual)

February 10, 2021

Study Completion (Actual)

March 25, 2021

Study Registration Dates

First Submitted

April 3, 2021

First Submitted That Met QC Criteria

April 6, 2021

First Posted (Actual)

April 8, 2021

Study Record Updates

Last Update Posted (Actual)

April 8, 2021

Last Update Submitted That Met QC Criteria

April 6, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Majmaah University

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data has been kept secure with the principal investigator Dr. Shahnaz Hasan and the sub-investigator due to the confidentiality issues.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Football Players

Clinical Trials on Resisted Sprint Traininig

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe